Skip to main content Accessibility help
×
Home

Information:

  • Access
  • Cited by 50

Actions:

      • Send article to Kindle

        To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

        Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

        Find out more about the Kindle Personal Document Service.

        ‘Bipolarity’ in bipolar disorder: Distribution of manic and depressive symptoms in a treated population
        Available formats
        ×

        Send article to Dropbox

        To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

        ‘Bipolarity’ in bipolar disorder: Distribution of manic and depressive symptoms in a treated population
        Available formats
        ×

        Send article to Google Drive

        To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

        ‘Bipolarity’ in bipolar disorder: Distribution of manic and depressive symptoms in a treated population
        Available formats
        ×
Export citation

Summary

Cross-sectional analysis of 441 individuals with bipolar disorder treated at a US health maintenance organisation investigated the distribution of manic and depressive symptoms in that illness. Clinically significant depressive symptoms occurred in 94.1% of those with (hypo)mania, while70.1% inadepressive episode had clinically significant manic symptoms. DSM-unrecognised depression-plus-hypomania was over twice as prevalent as DSM-recognised mixed episodes. Depressive symptoms were unimodally distributed in (hypo)mania. Depressive and manic symptoms were positively, not inversely correlated, and their co-occurrence was associated with worse quality of life. Implications for the DSM and ICD nosological systems are discussed.

Footnotes

Declaration of interest

None. Funding detailed in Acknowledgements.

First et al (Reference First, Pincus and Levin2004) recently proposed that diagnostic classification systems should have not only validity and reliability but also clinical utility. Systems such as DSM-IV (American Psychiatric Association, 2000) presume in their conceptualisation of (and name for) bipolar disorder that mania and depression are polar opposites, implying that their co-occurrence is atypical. However, their co-occurrence is common (e.g. Reference Akiskal, Bourgeois and AngstAkiskal et al, 2000), although most such research derives from samples from in-patient units, tertiary care clinics or private practice, identified on the basis of current episode. Therefore we investigated the distribution and co-occurrence of manic and depressive symptoms in a large, out-patient health maintenance organisation sample treated for bipolar disorder, assessed without regard to current episode status.

Fig. 1 Frequency distribution showing the number of participants with mania or hypomania who reported the given number of depressive symptoms. No evidence is seen for a bimodal distribution of participants between those who do and do not have depressive symptoms.

METHOD

Participants were assessed at intake for a randomised controlled trial of a care management system for bipolar disorder (Reference Simon, Ludman and UnutzerSimon et al, 2005). Importantly, the entire population of adults in treatment for bipolar disorder was sampled, yielding a treated, but not necessarily currently treatment-seeking, sample. Of 450 eligible patients, 441 (98%) enrolled. Participants and non-participants did not differ in age and gender, or in psychiatric hospitalisation and emergency room use in the previous year. The sample was 68% female, 88% Caucasian and 76% had bipolar I disorder.

As in other studies (e.g. Reference Judd, Akiskal and SchettlerJudd et al, 2002), severity of mania and depressive symptoms at intake were separately characterised as: remission or minimal symptoms (0-1 definite DSM symptom); sub-threshold symptoms (52 definite DSM symptoms, but not meeting DSM criteria for mood episode); or full episode (meets DSM criteria for depressive or hypomanic/manic episode). ‘Clinically significant' symptoms were defined a priori as 52 symptoms.

For depressive symptom counts during (hypo)mania, we excluded symptoms that could be ‘double-counted' for mania as well as depression (e.g. insomnia, distractibility), as in earlier work (Reference Bauer, Gyulai and YehBauer et al, 1994). Quality of life was assessed using the Short Form-36 (SF-36; Reference Stewart, Hays and WareStewart et al, 1988).

A w2-test was used to compare categorical variables and analysis of variance to compare interval data.

RESULTS

Distribution of clinical states

Clinically significant symptoms were present in 77.7% (343/441); 41.5% (183/441) were in DSM-defined mood episodes: depression (32.2%, 142/441), mania (2.9%, 13/441), hypomania (3.6%, 16/441), or mixed (mania-plus-depression, 2.7%, 12/441); 6.1% (27/441) met criteria for DSM-unrecognised hypomania-plus-depression. Overall, 15.4% (68/441) met criteria for mania or hypomania.

Of these 68 individuals, the vast majority (94.1%, 64/68) had clinically significant depressive symptoms. Conversely, 70.1% (108/154) of those in a major depressive episode had clinically significant manic symptoms. Of the 68, 17.6% (12/68) met criteria for DSM-recognised mixed episode, but 39.7% (27/68) met criteria for DSM-unrecognised hypomania-plus-depression.

Co-distribution of depressive and manic symptoms

Depressive symptoms among these 68 participants were unimodally, not bimodally, distributed (Fig. 1). There was a strong positive relationship between clinically significant depressive and manic symptoms: χ2-test of linear association (2)=75; P<0.001. Moreover, those with clinically significant manic symptoms who had more depressive symptoms also had progressively worse SF-36 mental (F(2)=35.5, P=0.001) and physical (F(2)=5.8, P=0.003) of quality life.

DISCUSSION

Limitations and strengths

This sample of individuals with treated bipolar disorder was assessed cross-sectionally as part of a clinical trial. None the less, it is informative for several reasons. This population is hitherto unrepresented in bipolar nosological studies. However, the data reflect clinical state without regard to patient or clinician decision to initiate clinical contact, and the assessment method allowed the identification of all combinations of symptoms.

Impact on nosology

Of the participants, 77.7% experienced clinically significant manic or depressive symptoms, and 41.5% were in a full mood episode - similar to a prior study of veterans (Reference Bauer, Kirk and GavinBauer et al, 2001). Thus, bipolar disorder is associated with substantial symptom load even in this insured, treated population.

A substantial gap appears in DSM-IV: those with DSM-unrecognised hypomanicplus-depressive episodes are more than twice as common than those with DSM-defined DSM-defined mixed episodes. Moreover, 70.1% of those in depressive episodes experience clinically significant manic symptoms.

Three findings provide strong evidence that this disorder is not, as a rule, truly ‘bipolar'. First, clinically significant depressive symptoms occurred in 91.4% of those with (hypo)mania. Conversely, 70.1% of those with depressive episodes had clinically significant manic symptoms. Second, depressive symptoms during (hypo)mania are unimodally, not bimodally, distributed. Third, the additive impact of manic and depressive symptoms on quality of life indicates that manic and depressive symptoms in this disorder are typically additive burdens, not alternative states.

Thus bipolar disorder is characterised less by swings between opposite ‘poles' of symptoms than by varying admixtures of manic and depressive symptoms, the combination of which is associated with greater dysfunction.

Finally, the co-occurrence of all degrees of depressive and manic symptoms suggests that a dimensional conceptualisation of mood state in this disorder is more valid than the categorical conceptualisation presumed by both the DSM and ICD (Reference Bauer, Tasman, Kay and LiebermanBauer, 2003). Accordingly, any categorical classification will be to some degree arbitrary and inaccurate. To apply Kendell's (Reference Kendell1982) metaphor: ‘Here, Nature has no joints to cleave'.

Clinical Implications and Limitations

CLINICAL IMPLICATIONS

  1. DSM-unrecognised mixed hypomania-plus-depression was twice as common as DSM-recognised mania-plus-depression (official mixed episodes), while admixtures of depressive and manic symptoms are the rule and not the exception.

  2. Bipolar disorder does not appear to be truly ‘bipolar' since manic and depressive symptoms are positively, rather than inversely, correlated.

  3. Manic and depressive symptoms in bipolar disorder appear to represent dimensions of symptomatology rather than discrete categories.

LIMITATIONS

  1. American out-patient health maintenance organisation sample.

  2. Cross-sectional analysis.

  3. No comparison with unipolar depression was included.

Acknowledgements

This work was supported in part by NIMH RO-1-59125 59125 (G.E.S.) and (G.E.S.) and VA Cooperative Cooperative Study No. 430 (M.S.B.).

References

Akiskal, H. S., Bourgeois, M. L., Angst, J., et al (2000) Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders. Journal of Affective Disorders, 59 (suppl. 1), S5S30.
American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders (4th edn, text revision) (DSM–IV–TR). Washington, DC: APA.
Bauer, M. S. (2003) Bipolar (manic–depressive) disorder. In Psychiatry (2nd edn) (eds Tasman, A., Kay, J. & Lieberman, J.), pp. 12371270. Philadelphia, PA: Saunders.
Bauer, M. S., Gyulai, L., Yeh, H-S., et al (1994) Testing definitions of dysphoric mania and hypomania: prevalence, clinical characteristics, and inter-episode stability. Journal of Affective Disorders, 32, 201211.
Bauer, M. S., Kirk, G., Gavin, C., et al (2001) Correlates of functional and economic outcome in bipolar disorder: a prospective study. Journal of Affective Disorders, 65, 231241.
First, M. B., Pincus, H. A., Levin, J. B., et al (2004) Clinical utility as a criterion for revising psychiatric diagnoses. American Journal of Psychiatry, 161, 946954.
Judd, L. L., Akiskal, H. S., Schettler, P. J., et al (2002) The long-term natural history of the weekly symptomatic status of bipolar I disorder. Archives of General Psychiatry, 59, 530537.
Kendell, R. (1982) The choice of diagnostic criteria for biological research. Archives of General Psychiatry, 39, 13341339.
Simon, G. E., Ludman, E. J., Unutzer, J., et al (2005) Randomized trial of a population-based care program for people with bipolar disorder. Psychological Medicine, 35, 1324.
Stewart, A., Hays, R. & Ware, J. (1988) The MOS short-form general health survey: reliability and validity in a patient population. Medical Care, 26, 724735.